长城彩票网页

朱东山
当前位置: 首页 >> 师资队伍 >> 专职教师 >> 朱东山
朱东山

职称:教授

导师:博士生导师

电话:156 5220 9841

邮箱:dongshan.zhu@uq.net.au

研究领域:慢性病防治;全球健康;纵向研究及生命历程流行病学;循证卫生政策

学习经历

2016.11-2020.05  澳大利亚昆士兰大学公共卫生学院获流行病学与卫生统计专业哲学博士学位(PhD)

2005.09-2008.07北京协和医学院公共卫生学院获社会医学和卫生事业管理硕士学位

2000.09-2005.07郑州大学公共卫生学院获医学学士学位


工作经历

2020.07--山东大学公共卫生学院教授/博导

2018.01-2018.07澳大利亚昆士兰大学公共卫生学院高级研究技师 (Senior Research Technician,兼职)

2014.07-2016.09  澳大利亚乔治全球健康研究院研究员(全职)

2008.07-2014.06中国民用航空局航空医学中心助理研究员(全职)

 

主要研究领域

1. 影响健康的社会、行为和环境决定因素及其相互作用与慢性病的防治;

2. 全球健康(Global Health);

3. 纵向研究(longitudinal study)及生命历程流行病学(Life-course Epidemiology);

4. 循证卫生政策。

本科生:待定

硕士生:待定

博士生:待定

近五年承担的主要研究课题:

1. 生命历程视角研究生殖健康与慢性疾病的国际合作研究 (InterLACE),海外项目:澳大利亚健康和医学研究委员会(NHMRC),2016.11-2020.01,230万,项目骨干成员(第三位);

2. 基础胰岛素治疗的观察登记性研究,中华医学会糖尿病学分会项目,2014.07 -2016.09,500万以上,项目骨干成员;

3. 民航飞行人员用药安全性评价方法和指标体系研究,省部级纵向项目:首都卫生发展科研专项,2012.12-2015.12,13.7万,项目负责人(PI)

1.Zhu D, Chung HF, Dobson A, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public Health. 2019; 4(11): PE553-E564. PMID: 31588031 (IF: 16.292, 中科院SCI-1)

2.Zhu D, Chung HF, Pandeya N, et al. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. PLoS Medicine. 2018;15(11):e1002704. PMID: 30481189. (IF: 11.68, 中科院SCI-1)

3.Zhu D, Chung HF, Dobson AJ, et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum Reprod. 2020;35(8):1933-43. doi:10.1093/humrep/deaa124 (IF: 5.733, 中科院SCI-1)

4.Zhu D*, Chung HF, Dobson AJ, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020. doi:10.1016/j.ajog.2020.06.039 (IF: 6.502, 中科院SCI-1)

5.Zhu D*, Chung HF, Pandeya N, et al. Premenopausal cardiovascular disease and age at natural menopause: a pooled analysis of over 170,000 women. European Journal of Epidemiology, 2019; 34(3):235-246. PMID: 30721378. (IF: 7.135, 中科院SCI-1)

6.Zhu D, Chung HF, Pandeya N, et al. Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies. European Journal of Epidemiology. 2018; 33(8):699-710. PMID: 29460096. (IF: 7.135, 中科院SCI-1)

7.Zhu D*, Mishra SR, Han X, Santo K. Social distancing in Latin America during the COVID-19 pandemic: an analysis using the Stringency Index and Google Community Mobility Reports. J Travel Med. 2020.IF: 7.089中科院SCI-2区)

8.Zhu. D*, Mishra. SR, Virani. SS. A way to track governments' response and people's mobility changes in response to COVID-19 pandemic. J Glob Health.2020(10):020345.IF3.079,中科院SCI-3区)

9.Zhu, D.*, Chung, H.F., Dobson, A, Pandeya, N and Mishra, G., 2019. P120: Women With Menopause After Age 45 And Take Hormone Therapy After Age 60 Increase The Risk Of Cardiovascular Disease. Circulation.(IF: 23.054, 中科院SCI-1)

10.Zhu, D.*, Chung, H.F., Pandeya, N., Dobson, A. and Mishra, G., 2019. Abstract MP28: Early Menopause is Associated With Early-Onset Cardiovascular Disease Before Age of 60 Years. Circulation, 139(Suppl_1), pp.AMP28-AMP28. (IF: 23.054, 中科院SCI-1)

11.Zhu, D., Chung, H.F., Pandeya, N., Dobson, A. and Mishra, G., 2019. Abstract 127: Premenopausal Cardiovascular Disease is Associated With Early Natural Menopause. Stroke, 50(Suppl_1), pp.A127-A127. https://doi.org/10.1161/str.50.suppl_1.127(IF: 6.24,中科院SCI-2)

12.Zhu D*, Zhang H, Li X, Ji J, Lu J, Jia W, Ji L and Zhang P. The lifestyle changes after initiating basal insulin in insulin naïve patients with type 2 diabetes: Results from the ORBIT study. Journal of Integrative Cardiology Open Access. 2019; 2(2):1-8 [IF: 1.46]

13.Zhu D*, Zhang H, Li X, Ji J, Cost Change After Initiating Basal Insulin for 6 Months in Patients with Type 2 Diabetes: A Registry Study in China. International Journal of Diabetes and Endocrinology. Vol. 4, No. 3, 2019, pp. 62-72. doi: 10.11648/j.ijde.20190403.11

14. Chung, H. F., Zhu, D., Dobson,et al. Age at menarche and risk of vasomotor menopausal symptoms: a pooled analysis of six studies. BJOG: An International Journal of Obstetrics &Gynaecology, 2020.(IF: 5.193,中科院SCI-2)

15. Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu, Y et al. (2017). Comparative effectiveness and safety of different basal insulins in a real-world setting [J]. Diabetes, Obesity and Metabolism, 2017, 19(8): 1116-1126. PMID: 28230322 (Second author. IF: 6.72, 中科院SCI-2)

16. Ji L, Zhang P, Zhu D, Li X, Ji J, Lu J, Guo X, Jia W, Weng J, Wu Y, Yang W. Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Reallife use of basal insulin in China. Diabetes, Obesity and Metabolism. 2017,19(6):822-830. PMID: 28105735 (Second author. IF: 6.72, 中科院SCI-2)

17. Yu Zhu, Puhong Zhang, Dongshan Zhu, Xian Li, Jiachao Ji, Linong Ji, and on behalf of the ORBIT Study Group. Predictors of Glycemic Control in Patients with Type 2 Diabetes: A Subgroup Analysis of the Observational Registry of Basal Insulin Treatment Study in China. Diabetes Technology & Therapeutics. 2018; 20(12): 825-832 DOI: 10.1089/dia.2018.0230 (IF: 4.392, 中科院SCI-3)

18.  Shu, H., Lu, J., Zhang, P., Zhu, D., Li, X., Ji, J., Zhao, F. and Ji, L., 2018. Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT study. Diabetes/metabolism research and reviews, 34(4), p.e2977. PMID: 29314667 (IF: 3.90, 中科院SCI-3)

19.  Chen J, Chen Y, Ji L, Zhang P, Zhu D, Li X, Ji J, Zhao F, Zhang H. Dose titration model and correlative factors analysis in Chinese patients with type-2 diabetes on basal insulin: results from an ORBIT study. EndokrynologiaPolska. PMID:29952407 (IF: 1.322, 中科院SCI-4)

20.  Luo Y, Bao Y, Zhang P, Zhu D, Li X, Ji J et al. (2017) Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes Before and After Initiating Basal Insulin Treatment in China. Diabetes Technology & Therapeutics 19(9):541-548, DOI: 10.1089/dia.2017.0040 (IF: 4.392, 中科院SCI-3)

21.  Zhang T., Ji L., Gao Y., Zhang P., Zhu D., Li X., Ji J., Zhao F., Zhang H. and Guo X., 2017. Observational registry of basal insulin treatment in patients with type 2 diabetes in China: safety and hypoglycemia predictors. Diabetes technology & therapeutics, 19(11), pp.675-684. PMID: 29090977 (IF: 4.392, 中科院SCI-3)

22.  Zhu, D., Zhang, H., Li, X., Ji, J., Lu, J., Jia, W., Ji, L. and Zhang, P., 2017, June. The Lifestyle Change after Initiating Basal Insulin in Insulin-Naive Patients with Type 2 Diabetes: Results from the ORBIT Study. In DIABETES (Vol. 66, pp. A262-A262). (IF: 8.68, 中科院SCI-1)

23.  Zhang, P., Zhang, H., Zhu, D., Li, X., Ji, J., Zhao, F., Lu, J., Jia, W. and Ji, L., 2018, October. Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China. In DIABETES-METABOLISM RESEARCH AND REVIEWS (Vol. 34). (IF: 3.90, 中科院SCI-3)

24.  Ji, L., Zhang, P., Zhu, D., Guo, X., Lu, J., Yang, W., Weng, J. and Garg, S.K., 2016, June. Glucose Control and Safety of Different Basal Insulin Therapies in Real-World Setting: ORBIT Study in China. In DIABETES (Vol. 65, pp. A245-A245) (IF: 8.68, 中科院SCI-1) 

25.  Zhang, H., Zhang, P., Luo, Y., Zhu, D., Li, X., Ji, J. and Ji, L., 2018, October. Basal insulin initiation on the top of metformin improves glycaemic control and safety in Chinese insulin-naive patients with type 2 diabetes. In DIABETOLOGIA (Vol. 61, pp. S441-S442. (IF: 6.02, 中科院SCI-2)

26.  Zhang, H., Zhang, P., Zhu, D., Li, X., Ji, J., Weng, J., Lu, J., Guo, X., Jia, W. and Ji, L., 2017, June. Predictors of Initiating Basal-Bolus Regimen in Type 2 Diabetes Patients with Uncontrolled Hyperglycemia by Oral Antidiabetic Drugs in China. In DIABETES (Vol. 66, pp. A261-A261). (IF: 8.68, 中科院SCI-1)

27.  Zhu, D., Li, X., Ji, J., Guo, X., Lu, J., Ji, L. and Zhang, P., 2016, November. Cost analysis in type 2 diabetes patients after initiating basal insulin for 6 months: an observational registry study from China. In DIABETES-METABOLISM RESEARCH AND REVIEWS (Vol. 32, No. SUPP 2, pp. 22-23). (IF: 3.26, 中科院SCI-3)

28.  Zhang, P., Bao, Y., Zhu, D., Li, X., Ji, J., Ji, L., Wu, Y. and Jia, W., 2016, November. Improvement in quality of life after initiation of basal insulin therapy: results from the ORBIT Study. In DIABETES-METABOLISM RESEARCH AND REVIEWS (Vol. 32, No. SUPP 2, pp. 3-3). (IF: 3.90, 中科院SCI-3)

29.  Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D. Comparative effectiveness and safety of three different basal insulins in patients with type 2 diabetes in a real world setting (ORBIT): a multicentre, prospective, registry study. The Lancet Diabetes & Endocrinology. 2016 Nov 30;4: S34. DOI: http://dx.doi.org/10.1016/S2213-8587(16)30389-8 (Second Author, IF: 19.74, 中科院SCI-1)

30.  Ji L, Zhang P, Weng J, Lu J, Guo X, Jia W, Yang W, Zou D, Zhou Z, Pan C, Gao Y, Li X, Zhu D, Li Y, Wu Y, Garg SK: Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China-Study Design and Baseline Characteristics. Diabetes technology & therapeutics 2015;17:735-744. PMID: 26171728 (IF: 4.392, 中科院SCI-3)

1. 荣誉称号或获奖

(1) 保罗?达德利?怀特国际学者Paul Dudley White International Scholar

Awarded by The American Heart Association(美国心脏协会授予)

(2) 2019年澳大利亚公共卫生协会高等研究学位卓越研究奖Australia Public Health Association HDR Excellence Prize 2019.


2. 奖学金获得情况

(1) 2019年度国家优秀自费留学生奖学金 (国家留学基金委颁发).

(2) 澳大利亚政府国际研究生研究奖学金International Postgraduate Research Scholarship (IPRS): 2016-2019, (澳大利亚联邦政府资助).

(3) 澳大利亚研究生奖学金Australian Postgraduate Award (APA): 2016-2019.

(4) 会议旅行奖学金:2018澳洲流行病学年会, 珀斯.

(5) 会议旅行奖学金: 2019国际卒中大会,夏威夷.

Oral (口头报告)

1.第十七届世界绝经大会(17 World Congress on the Menopause),2020年4月30 - 5月3日, 墨尔本,澳大利亚

2.  2019年浙江省“数字经济”国际青年人才论坛,2019年11月13-14日,杭州

3.2019年国际卒中大会 (美国心脏协会主办), 2019年2月6-8, 檀香山, 夏威夷,美国.

4.昆士兰州第三届心血管会议,2018年11月08日,布里斯班

5. 2018年临床和公共卫生论坛,2018年11月22-23, 布里斯班


Poster(墙报报告)

1. 2020年流行病和生活方式科学会(美国心脏协会主办)EPI|LIFESTYLE 2020 Scientific Sessions, 2020年3月3-6, 凤凰城, 亚利桑那, 美国

2. 2019年澳大利亚流行病学(AEA)年度科学会议, 2019年10月22-24,布里斯班

3. 2018年澳大利亚流行病学(AEA)年度科学会议, 2018年10月22-24,珀斯

4. 2019年流行病和生活方式科学会(美国心脏协会主办)EPI|LIFESTYLE 2019 Scientific Sessions, 2019年3月5-8, 休斯顿, 德克萨斯州, 美国

5. 2017年美国糖尿病协会第77届科学会,2017年6月 9- 13, 圣地亚哥

6. 2016年美国糖尿病协会第76届科学会,2016年6月10- 14, 新奥尔良

美国心脏病协会高级会员AHA Premium Membership before Fellowship;

中国卫生政策与管理学会(CHPAMS)会员。

Copyright © 2019 山东大学卫生管理与政策研究中心页 版权所有
地址:济南市文化西路44号 电话:0531-88382142 88382222 传真:0531-88382693 邮编:250012